RNase Inhibitor, Recombinant

Catalog number
9218-500
Name
RNase Inhibitor, Recombinant
Size
500 UN
Price
175.00 EUR
Supplier

Details

Background
Recombinant Human Placental RNase Inhibitor (rHPRI) binds and inhibits a broad range of eukaryotic RNases, including RNase A, RNase B, RNase C, and human placental RNase.
Concentration
N/A
Molecular weight
50.0 kDa
Synonym
Recombinant Human Placental RNase Inhibitor (rHPRI)
Other name
Recombinant Human Placental RNase Inhibitor (rHPRI)
Recombinant
Yes
Source
E. coli strain containing an overproducing clone of human placenta ribonuclease inhibitor.
Purification
≥90%
Tested applications
SDS-PAGE, N/A
Level of endotoxin
N/A
Tested activity
40 unit/μl
Biological activity
N/A
Reesults
N/A
Binding ability
N/A
Unit
One unit inhibits the activity of 5 ng of RNase A by 50%.
Storage condition
-20°C
Shipping under
Gel pack
Physical appearance
Liquid
Physical properties
Recombinant RNase Inhibitor in 20 mM HEPES (pH 7.6), 50 mM KCl, 8 mM DTT and 50% glycerol.
How to reconstitute
N/A
Aa sequence
N/A
Before use
Centrifuge the vial prior to opening.
Notes
For Research Use Only! Not to be used in humans
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
Additional source
Recombinants or rec. proteins
Group
recombinants